Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
Literatur
Ahluwalia P, Singhai RL (1981) Monoamine uptake into synaptosomes from various regions of rat brain following lithium administration and withdrawal. Neuropharmacology 20:483–487
Aldenhoff JB, Lux HD (1984) Lithium- und Kalzium-abhängige Zellfunktionen. Der Beitrag eines membranphysiologischen Untersuchungsansatzes zur Erklärung therapeutischer Lithiumwirkungen. Fortschr Neurol Psychiat 52:152–163
Allikmets LH, Stanley M, Gershon S (1979) The effect of lithium on chronic haloperidol enhanced apomorphin aggression in rats. Life Sci 25:165–170
Angrist B, Gershon S (1979) Variable attenuation of amphetamine effects by lithium. Amer J Psychiat 136:806–810
Arora RC, Fessier RG, Meltzer H Y (1983) Effects on lithium carbonate on serotonin uptake in rat blood platelets. Prog Neuropsychopharmacol Biol Psychiat 7:39–45
Banay-Schwartz M, Wajda I J, Manigault I, DeGuzman T, Lajtha A (1982) Lithium: Effect on (3H)spiperone binding, ionic content, and amino acid levels in the brain of rats. Neurochem Res 7:179–189
Belmaker RH (1981) Receptors, adenylate cyclase, depression and lithium. Biol Psychiat 16:333–350
Belmaker RH, Zohar J, Levy A (1982) Unindirectionality of lithium stabilization of adrenergic and cholinergic receptors. In: Emrich HM, Aldenhoff JB, Lux HD (eds) Basic mechanisms in the action of hthium. Excerpta Medica, Amsterdam Oxford Princeton, pp 146–153
Belmaker RH, Lerer B, Klein E, Newman M, Dick E (1983) Clinical implications of research on the mechanism of action of Hthium. Prog Neuropsychopharmacol Biol Psychiat 7:287–296
Berl S, Clarke DD (1975) Lithium and amino acid metabolism. In: Johnson FN (ed) Lithium research and therapy. Academic Press, London, pp 425–441
Berrettini WH, Nürnberger JI Jr, Hare TA, Simmons-AUing S, Gershon ES, Post RM (1983) Reduced plasma and CSF gamma-aminobutyric acid in affective illness: Effect of lithium carbonate. Biol Psychiat 18:185–194
Berridge MJ (1980) Receptors and calcium signalling. Trends Pharmacol Sci 2:419–424 Berridge MJ (1984) Inositol triphosphate and diacylglycerol as second messengers. Biochem. J 220:345–360
Birch NJ (1976) Possible mechanism for biological action of hthium. Nature 264:681
Birch NJ, Jenner FA (1973) The distribution of lithium and its effects on the distribution and excretion of other ions in the rat. Brit J Pharmacol 47:586–594
Bloom FE, Baetge G, Deyo S et al (1983) Chemical and physiological aspects of the actions of lithium and antidepressant drugs. Neuropharmacology 22:359–365
Brewerton TD, Reus VI (1983) Lithium carbonate and L-tryptophan in the treatment of bipolar and schizoaffective disorders. Amer J Psychiat 140:757–760
Bunney WE Jr, Garland BL (1983) Possible receptor effects of chronic lithium administration. Neuropharmacology 22:367–372
Bunney WE Jr, Murphy DL (eds) (1976) The neurobiology of lithium. Neurosci Res Prog Bull 14:111–206
Bunney WE Jr, Post RM, Amdisen AE, Kopanda RT (1977) A neuronal receptor sensitivity mechanism in affective illness. A review of evidence. Commun Psychopharmacol 1:393–405
Calker D van, Hamprecht B (1980) Effects of neurohormones on glia cells. In: Fedoroff S, Hertz L (eds) Advances in cellular neurobiology, vol 1. Academic Press, New York, pp 32–67
Cameron OG, Smith CB (1980) Comparison of acute and chronic lithium treatment on 3H-norepinephrine uptake by rat brain slices. Psychopharmacology 67:81–85
Canessa M, Adragna N, Solomon HS, Conolly TM, Tosteson DC (1980) Increased sodium-lithium countertransport in red cells of patients with essential hypertension. N Engl J Med 302:772–776
Colburn RW, Goodwin FK, Bunney WE Jr, Davis JM (1967) Effect of lithium on the uptake of noradrenaline by synaptosomes. Nature 215:1395–1397
Cooper TB, Gershon S, Kline NS, Schou M (eds) (1979) Lithium: Controversies and unresolved issues. Excerpta Medica, Amsterdam
Cornford EM, Braun LD, Oldendorf WH (1978) Carrier mediated blood-brain barrier transport of choline and certain choline analogs. J Neurochem 30:299–308
Corrodi H, Fuxe K, Hökfelt T, Schou M (1967) The effect of lithium on cerebral monoamine neurons. Psychopharmacologia 11:345–353
Corrodi H, Fuxe K, Schou M (1969) The effect of prolonged lithium administration on cerebral monoamine neurons in the rat. Life Sci 8:643–651
Creese I, Sibley DR (1981) Receptor adaptations to centrally acting drugs. Ann Rev Pharmacol Toxicol 21:357–391
Davis KL, Berger PA, Hollister LE, Barchas JD (1978) Cholinergic involvement in mental disorders. Life Sci 22:1865–1872
Deutsch SI, Stanley M, Peselow ED, Banay-Schwartz M (1983) Glycine: A possible role in lithiums action and affective illness. Neuropsychobiology 9:215–218
Doms E, Pandey GN, Shaughnessy R, Gaviria M, Val E, Ericksen S, Davis JM (1979) Lithium transport across red cell membrane: A cell membrane abnormality in manic-depressive illness. Science 205:932–934
Downes CP (1983) Inositol phospholipids and neurotransmitter-receptor signalling mechanisms. Trends Neuro Sci 6:313–316
Dubovsky SL, Franks RD (1983) Intracellular calcium ions in affective disorders: A review and an hypothesis. Biol Psychiat 18:781–797
Duhm J, Becker BF (1977) Studies on the lithium transport across the red cell membrane. II. Characterization of ouabain-sensitive and ouabain-insensitive Li+ transport. Effects of bicarbonate and dipyridamole. Pflügers Arch 367:211–219
Duhm J, Becker BF, Greil W (1979) Na+ dependent Li+ countertransport and the lithium distribution across the human erythrocyte membrane: An introduction. In: Obiols J, Gallus C, Monoclüs EG, Pujol J (eds) Biological psychiatry today. North-Holland Biomedical, Elsevier, pp 1137–1142
Ebstein R, Belmaker R, Grunhaus L, Rimon R (1976) Lithium inhibition of adrenaline-stimulated adenylate cyclase in humans. Nature 259:411–413
Ebstein RP, Eliashar S, Belmaker RH, Ben-Uriah Y, Yehuda S (1980) Chronic lithium treatment and dopamine-mediated behavior. Biol Psychiat 15:459–467
Ehrlich BE, Diamond JM (1980) Lithium, membranes, and manic-depressive illness. J Membr Biol 52:187–200
Eichner D, Opitz K (1974) Über den natürlichen Lithiumgehalt tierischer Gewebe. Histochemistry 42:295–300
Emrich HM (1982) Prophylactic therapies in affective disorders: Mode of action from a clinical point of view. In: Emrich HM; Aldenhoff JB, Lux HD (eds) Basic mechanisms in the action of lithium. Excerpta Medica, pp 202–214
Emrich HM, Zerssen D von, Kissling W, Möller H J, Windorfer A (1980) Effect of sodium valproate on mania. The GABA-hypothesis of affective disorders. Arch Psychiat Nervenkr 229:1–16
Emrich HM, Aldenhoff JB, Lux HD (eds) (1982) Basic mechanisms in the action of lithium. Excerpta Medica, Amsterdam Oxford Princeton
Fessier RG, Sturgeon RD, London SF, Meltzer H Y (1982) Effects of lithium on behaviour induced by phencyclidine and amphetamine in rats. Psychopharmacology 78:373–376
Friedman E, Dallob A, Levine G (1979) The effect of long-term lithium treatment on reserpine-induced supersensitivity in dopaminergic and serotonergic transmission. Life Sci 25: 1263–1266
Gallager DW, Bunney WE Jr (1979) Failure of chronic lithium treatment to block tricyclic antidepressant-induced 5-HT supersensitivity. Naunyn-Schmiedeberg’s Arch Pharmacol 307:129–133.
Gallager DW, Pert A, Bunney WE Jr (1978) Haloperidol-induced presynaptic dopamine supersensitivity is blocked by chronic lithium. Nature 273:309–312
Garver DL, Davis JM (1979) Biogenic amine hypotheses of affective disorders. Life Sci 24:383–394
Gorkin RA, Richelson E (1979) Lithium ion accumulation by cultured glioma cells. Brain Res 171:365–368
Gorkin RA, Richelson E (1981) Lithium transport by mquse neuroblastoma cells. Neuropharmacology 20:791–801
Gottesfeld Z, Ebstein BS, Samuel D (1971) Effect of lithium on concentration of glutamate and G AB A levels in amygdala and hypothalamus in rat. Nature New Biol 234:124–125
Greil W (1982) Zu den Mechanismen der Verteilung von Lithium zwischen Erythrozyten und Plasma. Nervenarzt 53:461–466
Greil W, Eisenried F (1978) Lithium uptake by erythrocytes of lithium-treated patients: Interin-dividual differences. In: Johnson FN, Johnson S (eds) Lithium in medical practice. MTP Press, Lancaster, pp 415–420
Greil W, Eisenried F, Becker BF, Duhm J (1977) Interindividual differences in the Na+-dependent Li+-distribution ratio across the red cell membrane amongst Li +-treated patients. Psychopharmacology 53:19–26
Greil W, Becker BF, Duhm J (1979) On the relevance of the red blood cell/plasma lithium ratio. In: Cooper TB, Gershon S, Kline NS, Schou M (eds) Lithium: Controversies and unresolved issues. Excerpta Medica, Amsterdam, pp 209–217
Haag M, Haag H, Eisenried F, Greil W (1984) RBC-choline: Changes by lithium and relation to prophylactic response. Acta Psychiat Scand 70:389–399
Hamprecht B (1977) Structural, electrophysiological and pharmacological properties of neuroblastoma x glioma hybrid cells in cell culture. Int Rev Cytol 49:99–170
Hanin I, Mallinger AG, Kopp V, Himmelhoch JM, Neil JF (1980 a) Mechanism of lithium- induced elevation in red blood cells choline content: An in vitro analysis. Commun Psycho-pharmacol 4:345–355
Hanin I, Kopp V, Spiker DG, Neil JF, Shaw DH, Kupfer DJ (1980 b) RBC and plasma choline levels in control and depressed individuals: A critical evaluation. Psychiat Res 3:345–355
Hendler NH (1978) Lithium pharmacology and physiology. In: Iversen LL, Iversen SD, Snyder SH (eds) Affective disorders: Drug action in animals and man. Plenum, New York London (Handbook of psychopharmacology, vol 14, pp 233–273)
Hermoni M, Lerer B, Ebstein RP, Belmaker RH (1980) Chronic lithium prevents reserpine-induced supersensitivity of adenylate cyclase. J Pharm Pharmacol 32:510–511
Hetmar O, Nielsen M, Braestrup C (1983) Decreased number of benzodiazepine receptors in frontal cortex of rat brain following long-term lithium treatment. J Neurochem 41:217–221
Hille B (1972) The permeability of the sodium channel to metal cations in myelinated nerve. J Gen Physiol 59:637–658
Honchar MP, Olney JW, Sherman WR (1983) Systemic cholinergic agents induce seizures and brain damage in lithium-treated rats. Science 220:323–325
Hong JS, Tilson HA, Yoshikawa K (1983) Effects of lithium and haloperidol administration on the rat brain levels of substance P. J Pharmacol Exp Ther 224:590–593
Horrobin DF (1979) Lithium as a regulator of prostaglandin synthesis. In: Cooper TB, Gershon S, Kline NS, Schou M (eds) Lithium: Controversies and unresolved issues. Excerpta Medica, Amsterdam, pp 854–880
Hunt GE, Beilharz GR, Storlien LH, Kuchel PW, Johnson GF (1983) The effect of lithium on rat erythrocyte choline, glycine and glutathione levels. Biochem Pharmacol 32:2981–2983
Janka Z, Szentistványi I, Juhász A, Rimanóczy A (1980) Difference in lithium transport between neurons and glia in primary culture. Neuropharmacology 19:827–829
Janowsky DS, El-Yousef MK, Davis JM, Sekerke HJ (1972) A cholinergic-adrenergic hypothesis of mania and depression. Lancet 11:632–635
Janowsky DS, Abrams AA, Groom GP, Judd LL, Cloptin P (1979) Lithium administration antagonizes cholinergic behavioral effects in rodents. Psychopharmacology 63:147–150
Janowsky DS, Risch SC, Gillin JC (1983) Adrenergic-cholinergic balance and the treatment of affective disorders. Prog Neuro Psychopharmacol Biol Psychiat 7:297–307
Jenden DJ, Jope RS, Fraser SL (1980) A mechanism for the accumulation of choline in erythrocytes during treatment with lithium. Comm Psychopharmacol 4:339–344
Jope RS (1979) Effects of lithium treatment in vitro and in vivo on acetylcholine metabolism in rat brain. J Neurochem 33:487–495
Jope RS, Jenden DJ, Ehrlich BE, Diamond JM (1978) Choline accumulates in erythrocytes during lithium therapy. New Engl J Med 299:833–834
Jope RS, Jenden DJ, Ehrlich BE, Diamond JM, Gosenfeld LF (1980) Erythrocyte choline concentrations are elevated in manic patients. Proc Natl Acad Sci USA 77:6144–6146
Kafka MS, Wirz-Justice A, Naber D, Marangos PJ, O’Donohue TL, Wehr TA (1982) Effect of lithium on circadian neurotransmitter receptor rhythms. Neuropsychobiology 8:41–50
Kämmen DP van, Murphy DL (1975) Attenuation of the euphoriant and activating effects of d- and 1-amphetamine by lithium carbonate treatment. Psychopharmacologia 44:215–224
Knapp S (1983) Lithium. In: Grahame-Smith DG, Cowen PJ (eds) Psychopharmacology, Part 1, Preclinical psychopharmacology. Excerpta Medica, Amsterdam, pp 71–106
Knapp S, Mandell AJ (1975) Effects of lithium chloride on parameters of biosynthetic capacity for 5-hydroxytryptamine in rat brain. J Pharmacol Exp Ther 193:812–823
Levitzki A, Atlas D (1981) A possible molecular mechanism for β-reeeptor desensitization: Experiments and hypotheses. Life Sci 28:661–672
Levy A, Zohar J, Belmaker RH (1982) The effect of chronic lithium pretreatment on rat brain muscarinic receptor regulation. Neuropharmacology 21:1199–1201
Lingsch C, Martin K (1976) An irreversible effect of Hthium administration to patients. Brit J Pharmac 57:323–327
Maggi A, Enna SJ (1980) Regional alterations in rat neurotransmitter systems following chronic lithium. J Neurochem 34:888–892
Michell B (1982) A link between lithium, lipids and receptors? Trends Biochem Sci 7:387–388
Millington WR, McCall AL, Wurtman RJ (1979) Lithium and brain choline levels. New Engl J Med 300:196–197
Miyauchi T, Orkawa S, Kitada Y (1980) Effects of lithium chloride on the cholinergic system in different brain regions in mice. Biochem Pharmacol 29:654–657
Müller-Oerlinghausen B (1985) Lithium long-term treatment — does it act via serotonin? Pharmacopsychiatry 18:214–217
Murphy DL, Donnelly C, Moskowitz J (1973) Inhibition by lithium of prostaglandin E and norepinephrine effects on cyclic adenosine monophosphate production in human platelets. Pharmac Therapeut 14:810–814
Olesen OV, Thomsen K (1976) A preventive effect of potassium against fatal Hthium intoxication in rats. Neuropsychobiology 2:112–117
Oppenheim G, Ebstein RP, Belmaker RH (1979) Effect of Hthium on the physostigmine-induced behavioral syndrome and plasma cyclic GMP. J Psychiat Res 15:133–138
Pandey GN, Dorus E, Davis JM, Tosteson DC (1979) Lithium transport in human red blood cells. Genetic and clinical aspects. Arch Gen Psychiat 36:902–908
Pert A, Bunney WE Jr (1982) Chronic Hthium modulates neurotransmitter receptor sensitivity. In: Emrich HM, Aldenhoff JB, Lux HD (eds) Basic mechanisms in the action of lithium. Excerpta Medica, Amsterdam, pp 121–132
Pert A, Rosenblatt E, Sivit C, Pert CB, Bunney WE Jr (1978) Long-term treatment with lithium prevents the development of dopamine receptor supersensitivity. Science 201:171–173
Pestronk A, Drachman DB (1980) Lithium reduces the number of acetylcholine receptors in skeletal muscle. Science 210:342–343
Plenge P, Mellerup ET (1982) 3H-imipramine high-affinity binding sites in rat brain. Effects of imipramine and lithium. Psychopharmacology (Berlin) 77:94–97
Poitou P, Bohuon C (1975) Catecholamine metaboHsm in the rat brain after short and long term Hthium administration. J Neurochem 25:535–537
Reches A, Wagner HR, Jackson V, Fahn S (1982) Chronic lithium administration has no effect on haloperidol-induced supersensitivity of pre- and postsynaptic dopamine receptors in rat brain. Brain Res 246:172–177
Reiser G, Duhm J (1982) Transport pathways for lithium ions in neuroblastoma x glioma hybrid cells at ‘therapeutic’ concentrations of Li +. Brain Res 252:247–258
Reiser G, Scholz F, Hamprecht B (1982) Pharmacological and electrophysiological characterization of lithium ion flux through the action potential sodium channel in neuroblastoma x glioma hybrid cells. J Neurochem 39:228–234
Richelson E (1977) Lithium ion-entry through the sodium channel of cultured mouse neuroblastoma cells: A biochemical study. Science 196:1001–1002
Rosenblatt JE, Pert CB, TaUman JF, Pert A, Bunney WE Jr (1979) The effect of imipramine and lithium on a- and ß-reeeptor binding in rat brain. Brain Res 160:186–191
Rotman A (1983) Blood platelets in psychopharmacological research. Prog Neuropsychophar-macol Biol Psychiat 7:135–151
Roufogalis BD (1980) Calmodulin: Its role in synaptic transmission. Trends Neuro Sci 3:238–241
Sachar EJ, Baron M (1979) The biology of affective disorders. Ann Rev Neurosci 2:505–518
Samples J, Janowsky DS, Pechnick R, Judd RL (1977) Lethal effects of physostigmine plus Hthium in rats. Psychopharmacology 52:307–309
Sangdee C, Franz DN (1980) Lithium enhancement of central 5-HT transmission induced by 5-HT-precursors. Biol Psychiat 15:59–68
Saneto RP, Srivastava SK, Werrbach-Perez K, Perez-Polo JR (1980) Lithium uptake at physiological ion concentrations in a human clonal neuroblastoma cell line. J Neurochem 34:1520–1521
Schou M, Mellerup ET, Rafaelson OJ (1981) Mode of action of lithium. In: Praag H van, Lader MH, Rafaelson OJ, Sachar EJ (eds) Brain mechanism and abnormal behavior — chemistry. Dekker, New York Basel (Handbook of Biological Psychiatry, part IV, pp 805–824)
Shaw DM (1975) Lithium and amine metabolism. In: Johnson FN (ed) Lithium research and therapy. Academic Press, London, pp 411–423
Staunton DA, Magistretti PJ, Shoemaker WJ, Bloom FE (1982 a) Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. I. Locomotor activity and behavioral supersensitivity. Brain Res 232:391–400
Staunton DA, Magistretti PJ, Shoemaker WJ, Deyo S, Bloom FE (1982 b) Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity. Brain Res 232:401–412
Sulser F, Vetulani J, Mobley PL (1978) Mode of action of antidepressant drugs. Biochem Pharmacol 27:257–261
Swann AC, Heninger GR, Roth RH, Maas JW (1981) Differential effects of short and long-term lithium on tryptophan uptake and serotonergic function in cat brain. Life Sci 28:347–354
Szentistványi I, Janka Z, Joó F, Rimanóczy A, Juhász A, Latzkovits L (1979) Na-dependent Li-transport in primary nerve cell cultures. Neurosci Lett 13:157–161
Tanimoto K, Maeda K, Terada T (1983) Inhibitory effect of lithium on neuroleptic and serotonin receptors in rat brain. Brain Res 265:148–151
Treiser S, Kellar KJ (1979) Lithium effect on adrenergic receptor supersensitivity in rat brain. Eur J Pharmacol 58:85–86
Treiser SL, Cascio CS, O’Donohue TL, Thoa NB, Jacobowitz DM, Kellar KJ (1981) Lithium increases serotonin release and decreases serotonin receptors in the hippocampus. Science 213:1529–1531
Verimer T, Goodale DB, Long JP, Flynn JR (1980) Lithium effects on haloperidol-induced pre-and postsynaptic dopamine receptor supersensitivity. J Pharm Pharmacol 32:665–666
Vizi ES (1975) Lithium and acetylcholine metabolism. In: Johnson FN (ed) Lithium research and therapy. Academic Press, London, pp 391–409
Yen MH, Reed DJ (1981) Regulation of lithium in cerebrospinal fluid of the cat by the choroid plexus isolated in situ. Arch Int Pharmacodyn 251:217
Yuwiler A, Bennett BL, Brammer GL, Geller E (1979) Lithium treatment and tryptophan transport through the blood brain barrier. Biochem Pharmacol 28:2709–2712
Zatz M (1979) Low concentrations of lithium inhibit the synthesis of cyclic AMP and cyclic GMP in the rat pineal gland. J Neurochem 32:1315–1321
Zohar J, Lerer B, Ebstein RP, Belmaker RH (1982) Lithium does not prevent agonist-induced subsensitivity of human adenylate cyclase. Biol Psychiat 17:343–350
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
van Calker, D., Greil, W. (1986). Biochemische und zellphysiologische Effekte von Lithiumionen. In: Müller-Oerlinghausen, B., Greil, W. (eds) Die Lithiumtherapie Nutzen, Risiken, Alternativen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-96935-5_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-96935-5_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-96936-2
Online ISBN: 978-3-642-96935-5
eBook Packages: Springer Book Archive